244 related articles for article (PubMed ID: 32194154)
21. Repeated human leukocyte antigens eplets, importance of typing the partner.
Dos Reis Ferreira C; da Silva Fernandes VM; Tafulo SCR; Cerqueira A; Rocha ACB; Nunes ATPM; Ferreira IPCN; Santos MJC; Pinho ATMT; Tavares IC; Guerra MMBB; Norton SMMS
Transpl Immunol; 2024 Jun; 84():102049. PubMed ID: 38729449
[TBL] [Abstract][Full Text] [Related]
22. Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.
Salvadé I; Aubert V; Venetz JP; Golshayan D; Saouli AC; Matter M; Rotman S; Pantaleo G; Pascual M
Hum Immunol; 2016 Jun; 77(6):483-9. PubMed ID: 27085791
[TBL] [Abstract][Full Text] [Related]
23. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
[TBL] [Abstract][Full Text] [Related]
24. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P
Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907
[TBL] [Abstract][Full Text] [Related]
25. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
Tafulo S; Osório E; Mendes C; Liwski R
Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
27. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
[TBL] [Abstract][Full Text] [Related]
28. Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
Thammanichanond D; Parapiboon W; Mongkolsuk T; Worawichawong S; Tammakorn C; Kitpoka P
Transplant Proc; 2018 Oct; 50(8):2548-2552. PubMed ID: 30316396
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
[TBL] [Abstract][Full Text] [Related]
30. Antihuman leukocyte antigen–specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches.
Batal I; Zeevi A; Lunz JG; Aggarwal N; Shapiro R; Randhawa P; Girnita A
Arch Pathol Lab Med; 2010 Oct; 134(10):1534-40. PubMed ID: 20923311
[TBL] [Abstract][Full Text] [Related]
31. Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.
Meneghini M; Melilli E; Martorell J; Revuelta I; Rigol-Monzó E; Manonelles A; Montero N; Cucchiari D; Diekmann F; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
Kidney Int Rep; 2018 Jul; 3(4):926-938. PubMed ID: 29989033
[TBL] [Abstract][Full Text] [Related]
32. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
[TBL] [Abstract][Full Text] [Related]
33. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
Pandey S; Harville TO
Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
[TBL] [Abstract][Full Text] [Related]
34. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
35. The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation - Data from the Swiss transplant cohort study.
Frischknecht L; Deng Y; Wehmeier C; de Rougemont O; Villard J; Ferrari-Lacraz S; Golshayan D; Gannagé M; Binet I; Wirthmueller U; Sidler D; Schachtner T; Schaub S; Nilsson J;
Front Immunol; 2022; 13():1005790. PubMed ID: 36211367
[TBL] [Abstract][Full Text] [Related]
36. Role of Pretransplant Complement-fixing Donor-specific Antibodies Identified by C1q Assay in Kidney Transplantation.
Thammanichanond D; Wiwattanathum P; Mongkolsuk T; Kantachuvesiri S; Worawichawong S; Vallipakorn SA; Kitpoka P
Transplant Proc; 2016 Apr; 48(3):756-60. PubMed ID: 27234729
[TBL] [Abstract][Full Text] [Related]
37. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
[TBL] [Abstract][Full Text] [Related]
39. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
Yanyiam P; Kantachuvesiri S; Thammanichanond D
Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
[TBL] [Abstract][Full Text] [Related]
40. Virtual crossmatch in kidney transplantation.
Piazza A; Ozzella G; Poggi E; Caputo D; Manfreda A; Adorno D
Transplant Proc; 2014 Sep; 46(7):2195-8. PubMed ID: 25242749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
